Cargando…
Methods for Evaluating Cell-Specific, Cell-Internalizing RNA Aptamers
Recent clinical trials of small interfering RNAs (siRNAs) highlight the need for robust delivery technologies that will facilitate the successful application of these therapeutics to humans. Arguably, cell targeting by conjugation to cell-specific ligands provides a viable solution to this problem....
Autores principales: | Hernandez, Luiza I., Flenker, Katie S., Hernandez, Frank J., Klingelhutz, Aloysius J., II, James O. McNamara, Giangrande, Paloma H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722562/ https://www.ncbi.nlm.nih.gov/pubmed/23894227 http://dx.doi.org/10.3390/ph6030295 |
Ejemplares similares
-
Delivery of chemo-sensitizing siRNAs to HER2(+)-breast cancer cells using RNA aptamers
por: Thiel, Kristina W., et al.
Publicado: (2012) -
Rapid Identification of Cell-Specific, Internalizing RNA Aptamers with Bioinformatics Analyses of a Cell-Based Aptamer Selection
por: Thiel, William H., et al.
Publicado: (2012) -
Targeted Inhibition of Prostate Cancer Metastases with an RNA Aptamer to Prostate-specific Membrane Antigen
por: Dassie, Justin P, et al.
Publicado: (2014) -
Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects
por: Kruspe, Sven, et al.
Publicado: (2017) -
Selection of a novel cell-internalizing RNA aptamer specific for CD22 antigen in B cell acute lymphoblastic leukemia
por: Ruiz-Ciancio, Dario, et al.
Publicado: (2023)